Posted by Michael Wonder on 05 Aug 2021
Health Canada approves Arazlo lotion for acne vulgaris treatment
4 August 2021 - Bausch Health said that Health Canada has approved the Notice of Compliance for Arazlo ( tazarotene) 0.045% lotion for the topical treatment of acne vulgaris (common acne) in patients 10 years of age and older.
Aralzo is the third new dermatology treatment from Bausch Health, Canada approved by Health Canada in just over 12 months.
